Repurposed Therapeutics, Inc.

Quick facts

Marketed products

• Transdermal Scopolamine · Gastroenterology / Neurology
  Transdermal scopolamine blocks muscarinic acetylcholine receptors to reduce motion sickness and nausea by decreasing vestibular sensitivity and gastric motility.

Phase 3 pipeline

• DPI-386 Nasal Gel
  DPI-386 is a repurposed therapeutic delivered as a nasal gel formulation, designed to provide local or systemic therapeutic effects through intranasal administration.
• scopolamine HBr · Neurology / Gastroenterology
  Scopolamine HBr is an anticholinergic agent that blocks muscarinic acetylcholine receptors to reduce secretions and motion-induced nausea.

Competitive intelligence

For the full portfolio CI brief — phase mix, recent regulatory actions, upcoming PDUFA dates, patent timeline, class-overlap with competitors:

• Repurposed Therapeutics, Inc. portfolio CI brief
• Repurposed Therapeutics, Inc. pipeline updates RSS